Skip to main content
eLearning Center

A Primer: Solving the Unique Problems of Orphan Drug Communications Programs

Posted: January 7, 2014
By: LaVoie Group

This paper outlines the considerations that must be taken into account when planning orphan disease drug communication programs and the best practice approaches to implementing them successfully through pre-approval, approval and post-approval phases.

For instance:

  • Learn the special characteristics of the rare disease environment
  • Create integrated programs that respond to those idiosyncrasies

Challenges can be met and opportunities realized with carefully planned and intelligently integrated communications programs that focus on best practices and solutions that balance the diverse needs by using experience, key learnings from mistakes as well as successes.


Share this content with your network.

Download Your Free Copy

(* Required)

By clicking this 'Download Now' box, you consent to BioCentury forwarding your information to the company that wrote this White Paper and you agree that said company can use it in accordance with their privacy policy.